Jensen Huang, CEO of artificial intelligence (AI) chip giant Nvidia, announced today that the company will acquire a minority stake in Doctolib, a French healthcare platform that aims to leverage AI to improve medical services.
According to reports from Agence France-Presse (AFP) and Reuters, Doctolib is a private platform that allows patients to book appointments with doctors; it has recently expanded to enable patients to store and share their medical records.
In August of this year, Doctolib launched a research initiative focused on using AI to analyze data from its 50 million users, with the goal of enhancing the user experience within the healthcare system.
While the specific value of the proposed investment has not been disclosed, Jensen Huang noted at a press conference in Paris that Nvidia invested at least $8 billion in Europe last year.
Stanislas Niox-Chateau, CEO of Doctolib, told AFP that the funding will help the company accelerate talent recruitment and the development of its own internal AI models. These models will power personal assistants for patients and physicians, while also assisting with administrative tasks.
He added that the company intends to use Nvidia chips to run these AI models, ensuring it retains autonomous control over both the models and patient data—opting against the use of proprietary AI models provided by companies like OpenAI or Anthropic.
Earlier this year, Doctolib completed a new round of financing, bringing its valuation to €3.6 billion.
The French newspaper Les Echos reported today that Nvidia has agreed to acquire stakes in four French tech startups: Doctolib, Genesis AI, Pigment, and Entalpic.
Leave a Reply